Negoro, S <br/><br/>
[A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group].  [electronic resource] 

 -  Gan to kagaku ryoho. Cancer & chemotherapy  May 1991 
 - 1013-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0385-0684 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Anorexia--chemically induced<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Camptothecin--administration & dosage<br/>Carcinoma, Small Cell--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Irinotecan<br/>Leukopenia--chemically induced<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Vomiting--chemically induced